Dopaminergic NeuronsNeuronsDopamineMesencephalonSubstantia NigraTyrosine 3-MonooxygenaseParkinson DiseaseOxidopamine1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineParkinsonian DisordersCorpus StriatumNeurons, AfferentMPTP Poisoning1-Methyl-4-phenylpyridiniumDopamine AgentsVentral Tegmental AreaNuclear Receptor Subfamily 4, Group A, Member 2Motor Neuronsalpha-SynucleinReceptors, DopamineDopamine Plasma Membrane Transport ProteinsParkinson Disease, SecondaryNerve DegenerationReceptors, Dopamine D2Dopamine AntagonistsDopamine AgonistsNerve Tissue ProteinsLevodopa3,4-Dihydroxyphenylacetic AcidAction PotentialsRats, Sprague-DawleyBrainRotenoneCells, CulturedNeuroprotective AgentsImmunohistochemistryNeostriatumReceptors, Dopamine D1Mice, Inbred C57BLAdrenergic AgentsVesicular Monoamine Transport Proteinsgamma-Aminobutyric AcidBehavior, AnimalGlial Cell Line-Derived Neurotrophic FactorApomorphineGABAergic NeuronsNeurotoxinsParaquatRats, WistarSynaptic TransmissionDisease Models, AnimalSulpirideTegmentum MesencephaliCell DeathDiencephalonCell CountPatch-Clamp TechniquesQuinpiroleAnimals, NewbornElectrophysiologyAxonsDendritesMicrogliaHomovanillic AcidAntiparkinson AgentsSynucleinsCholinergic NeuronsElectric StimulationMice, TransgenicSynapsesLewy BodiesMice, KnockoutTime FactorsBenzazepinesHaloperidolNeural InhibitionNerve Growth FactorsMotor ActivityDose-Response Relationship, DrugHippocampusCell DifferentiationCerebral CortexBrain Tissue TransplantationHerbicidesBasal GangliaSerotoninAnalysis of VarianceMembrane PotentialsReceptors, Dopamine D3Cell Survival2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepineNeurogenesisAmphetamineModels, NeurologicalAnimals, Genetically ModifiedNeurogliaFetal Tissue TransplantationGreen Fluorescent ProteinsDihydroxyphenylalaninePresynaptic Terminals